Skip to main content
Fig. 3 | Antimicrobial Resistance & Infection Control

Fig. 3

From: Network meta-analysis and pharmacoeconomic evaluation of antibiotics for the treatment of patients infected with complicated skin and soft structure infection and hospital-acquired or ventilator-associated penumonia

Fig. 3

Network plot of eligible comparisons for primary outcome in HAP/VAP group. The size of the node corresponds to the number of individual studies. The directly compared interventions are linked with a line, the width of which is proportional to the number of studies assessing respective comparisons. Numbers above the lines indicate studies. SXT, trimethoprim/sulfamethoxazole

Back to article page